Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Share News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 621.50
Bid: 622.00
Ask: 622.50
Change: 6.00 (0.97%)
Spread: 0.50 (0.08%)
Open: 622.00
High: 635.50
Low: 618.50
Prev. Close: 615.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Haleon appoints Tate & Lyle's finance chief as CFO from November

Wed, 24th Apr 2024 09:15

(Alliance News) - Haleon PLC on Wednesday said it has appointed Tate & Lyle PLC's Dawn Allen as chief financial officer.

Weybridge, Surrey-based consumer healthcare company Haleon said Allen will leave her current role as CFO at London-based sweetener and food ingredients supplier Tate & Lyle and join Haleon on October 28, before joining the board and assuming the role of Haleon CFO from November 1.

The appointment follows Tobias Hestler informing the Haleon board that he will step down as CFO to "better balance work demands with the management of a long-term health condition", Haleon said.

Hestler will resign from the board on November 1, before remaining with Haleon until the end of the year.

Tate & Lyle noted the timing of Allen's departure will allow it to close out its half-year results ending September 30 under her financial leadership, while it has begun a process to appoint a successor.

A further announcement will be made "in due course", Tate & Lyle said.

Prior to joining Tate & Lyle, Allen had a 25-year career at Mars Inc, where she was most recently global CFO and vice president for Global Transformation.

Haleon Chief Executive Officer Brian McNamara said: "She has a proven track record as a CFO with extensive consumer and international experience and will be a great addition to our executive team. I want to take this opportunity to thank Tobias for his significant contribution in creating Haleon as a standalone business and for the close partnership over the last few years. He has played a critical role in shaping and building Haleon's foundations and putting us on a path for long-term success.

Tate & Lyle CEO Nick Hampton commented: "During her time at Tate & Lyle, Dawn has played a key role in maintaining strong financial discipline across the business, and leaves behind a proven team that will continue to support the delivery of our growth-focused strategy."

Shares in Haleon were up 0.9% to 335.62 pence each in London on Wednesday morning, while Tate & Lyle shares were down 0.5% to 642.00p each.

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
24 Sep 2014 09:15

Wednesday broker round-up UPDATE

Aggreko: Morgan Stanley ups target price from 1350p to 1375p, while leaving its underweight rating unaltered. Alliance Pharma: Canaccord Genuity lowers target price from 35p to 33p reiterating its hold recommendation. Close Brothers Group: UBS moves target price from 1420p to 1430p and keeps a neut

Read more
24 Sep 2014 08:32

UK BROKER RATINGS: Davy Upgrades Wolseley, UBS Likes Fresnillo

Read more
24 Sep 2014 07:28

UK MORNING BRIEFING: Fresnillo Is 'Most Preferred' But Not Tate & Lyle

Read more
23 Sep 2014 16:18

MARKET COMMENT: UK Stocks Fall Again As US Announces Tax Clampdown

Read more
23 Sep 2014 14:55

FTSE 250 movers: Tate & Lyle slides after profit warning

Sweetener maker Tate & Lyle led the downside after issuing a profit warning. It blamed severe US weather and the temporary shutdown of a plant in Singapore for higher costs, but did also say that sales of its flagship Splenda sucralose sweetener were ahead of last year. It admitted that the first ha

Read more
23 Sep 2014 13:50

UK profit warnings prompt investor wake-up call

* Tesco, Tate & Lyle woes hit faith in valuation premium * Price gap relative to Europe will keep closing-strategist * UK company earnings upgrades already lagging Europe's By Lionel Laurent and Tricia Wright LONDON, Sept 23 (Reuters) - Profit warnings and share-price slid

Read more
23 Sep 2014 13:16

UPDATE 2-Tate & Lyle shares plunge to 3-year low after profit warning

* Taking longer than expected to make up winter shortfall * New CFO leading review of planning, supply chain * Sucralose prices seen down 25 pct this year, not 15 pct * Sees adj profit of 230-245 mln pounds, below analyst estimates * Shares plunge 16 percent (Adds compan

Read more
23 Sep 2014 12:38

London midday: Stocks drop as US Treasury acts to block tax inversion deals

UK stocks were firmly lower come midday, tracking overnight losses on Wall Street, with investors apparently reacting the US Treasury's move last night to make corporate tax inversions more difficult. Acting as a backdrop, traders were monitoring the first coalition airstrikes against Islamic State

Read more
23 Sep 2014 11:58

CORRECT: UK MIDDAY BRIEFING: FCA Fines Barclays Again For Client Asset Breaches

Read more
23 Sep 2014 11:43

UK MIDDAY BRIEFING: FCA Issues Its Biggest Ever Fine To Barclays

Read more
23 Sep 2014 10:35

TOP NEWS: Tesco CFO To Start Immediately, As Data Shows Sales Drop

Read more
23 Sep 2014 09:35

MARKET COMMENT: Pharmaceuticals And Grocers Weigh Down FTSE 100

Read more
23 Sep 2014 07:42

London pre-open: FTSE to edge lower ahead of Eurozone PMIs

UK-listed stocks were forecast to register a small decline at Tuesday's opening bell, extending losses seen both at home and abroad the previous day. City sources predict the FTSE 100 will open around four points higher than yesterday's close of 6,773.63. CMC market analyst Jasper Lawler said: "Eur

Read more
23 Sep 2014 07:37

Tate & Lyle warns on profits after bad US weather

Sweetener maker Tate & Lyle blamed severe US weather and the temporary shutdown of a plant in Singapore for higher costs and a profit warning, although it said sales of its flagship Splenda sucralose sweetener were ahead of last year. Tate & Lyle said the first half of the year had been very challen

Read more
23 Sep 2014 07:27

UK MORNING BRIEFING: Drug Stocks Lead Decline On Inversion Crackdown

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.